Activation of TRPV1 enhanced mRNA level and protein level of IL-6 in FLS from RA and OA patient and application of TRPV1 antagonist could be therapeutic strategy to modulate nociception from arthritis.73 This evidence concerns the gene TRPV1 and arthritic joint disease.